Abstract
Interindividual differences in the psychotomimetic response to the N-methyl-d-aspartate receptor antagonist ketamine are commonly observed. The apolipoprotein E (APOE) ε4 allele has been associated with reduced severity of positive psychotic symptoms in schizophrenia. In this study, we sought to determine if the APOE ε4 allele influences the psychotomimetic response to ketamine in schizophrenics. Eighteen patients genotyped at the APOE locus underwent a double-blind infusion of ketamine and of placebo. Ketamine-induced alterations in the brief psychiatric rating scale factors were compared between schizophrenics with and without the APOE ε4 allele. APOE ε4+ schizophrenics displayed significantly reduced ketamine-induced psychosis, as compared to ε4− patients. These preliminary data indicate that the psychotomimetic response to ketamine may be genetically influenced and may provide additional evidence that APOE may modify expression of the positive symptoms in schizophrenia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Benjamin J, Greenberg B, Murphy DL, Lin L, Patterson C, Hamer DH . (1996): Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet 12: 81–84
Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D . (1997): Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiat 154: 805–811
Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett E, Nemanov L, Katz M, Melmaker R . (1996): Dopamine D4 receptor (D4DR) exon III polymorphism associated with human personality trait of novelty-seeking. Nature Genet 12: 78–80
Harada S, Agarwal DP, Goedde HW . (1985): Aldehyde dehydrogenase polymorphism and alcohol metabolism in alcoholics. Alcohol 2: 391–392
Hixson JE, Vernier DT . (1990): Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545–548
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremmer JD, Heninger GR, Bowers MB Jr, Charney DS . (1994): Subanesthetic effects of noncompetitive NMDA antagonist, ketamine, in humans: Psychomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiat 51: 199–214
Lahti AC, Koffel B, LaPorte D, Tamminga CA . (1995): Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9–19
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL . (1996): Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527–1531
Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A . (1997): Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141–150
Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A . (1997): Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine. Biol Psychiat 42: 664–668
Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A . (1996): NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301–307
Malhotra AK, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D . (1996): The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiat 1: 388–391
Miyata M, Smith JD . (1996): Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14: 55–61
Overall JE, Gorham DR . (1962): The brief psychiatric rating scale. Psychol Rep 10: 799–812
Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D . (1997): Apolipoprotein E ε4 allele and clinical phenotype in schizophrenia. Lancet 350: 930–931
Spitzer RL, Williams JBW, Gibbon M, First MB . (1990): Structured Clinical Interview for DSM-III-R —Patient Version 1.0 (SCID-P). Washington, DC, American Psychiatric Press
Strittmatter WJ, Roses AD . (1995): Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 92: 4725–4727
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malhotra, A., Breier, A., Goldman, D. et al. The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report. Neuropsychopharmacol 19, 445–448 (1998). https://doi.org/10.1016/S0893-133X(98)00031-1
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(98)00031-1
Keywords
This article is cited by
-
Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference
Neuropsychopharmacology (2011)
-
A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia
Molecular Psychiatry (2008)
-
Acute and chronic effects of ketamine upon human memory: a review
Psychopharmacology (2006)
-
Greater vulnerability to the amnestic effects of ketamine in males
Psychopharmacology (2006)
